$VTEX

do Carmo Thomaz Junior Geraldo sold $321K of VTEX

do Carmo Thomaz Junior Geraldo (Chief Executive Officer) sold 82,054 shares of VTEX (VTEX) at $3.91 ($0.32M total) on 2026-06-02.

Original reporting
SEC EDGAR · do Carmo Thomaz Junior Geraldo
Published Jun 3, 2026, 7:40 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 3, 2026, 8:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VTEX
Neutral
medium confidence
Mentioned
$VTEX
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VTEXNeutralLow
01

Why it matters

This is primarily a sentiment/positioning datapoint; it does not introduce operational or financial changes. Traders may briefly reassess near-term sentiment, but the lack of fundamental catalysts limits sustained repricing.

02

Market read

Insider selling disclosure can influence short-term sentiment, but without accompanying company-specific news, expected impact is modest.

03

What to watch

The absence of a stated 10b5-1 plan can increase speculation, but the article provides no rationale, volume context versus prior sales, or any concurrent company news.

Relevance 7/10Novelty 6/10Timing: Filed June 3, covering a sale executed June 2

Background

The article is an SEC Form 4 insider transaction disclosure for VTEX, reporting an officer/direct sale of common stock.

Company-level read

Ticker impact

$VTEXNeutralMedium confidence
Context

SEC Form 4 shows VTEX CEO sold 82,054 shares in an open-market transaction, signaling insider liquidity activity for the issuer.

Expected impact

Likely limited, short-lived impact; any reaction should fade unless accompanied by other company-specific catalysts.

Evidence & confidence

The filing provides a specific sale price/date and share count, but does not disclose earnings, guidance, deals, or regulatory actions that would directly reprice fundamentals.

Market effects

Minimal—single-company insider sale without broader sector/regulatory context.

Minimal—US-listed issuer filing; no stated cross-border transaction impact.

Minimal—no deal, trial, or macro linkage described.

Counterpoint

CEO selling may reflect diversification/liquidity needs rather than negative expectations, especially since the sale is disclosed with execution details.

Key entities

  • VTEX

    Company whose CEO reported an open-market sale of 82,054 shares via SEC Form 4.

  • do Carmo Thomaz Junior Geraldo

    VTEX CEO who sold $320.8K of shares; transaction code S (open-market sale).

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VTEXMed

VTEX (VTEX) Just Turned A Profit Corner, But Growth Is Slowing

VTEX (NYSE:VTEX) reported Q2 2026 results showing improved profitability with non-GAAP income from operations up 62.4% YoY to $13.8M, and free cash flow up 79.1% to $12.7M. However, revenue growth slowed to 1.3% YoY on an FX-neutral basis, with management expecting flat growth for Q3. The company repurchased 6.2M shares for $23.2M during the quarter.

$VTEXMedAI 8/10

VTEX (VTEX) Q2 2026 Earnings Call Transcript

VTEX reported Q2 2026 results in an earnings call. GMV was $5.7B, up 7% FX-neutral. Subscription revenue was $63.8M, up 1.3% FX-neutral. Non-GAAP operating income rose 62% to $13.8M, with a 21.4% margin. Free cash flow was $12.7M, up 79%. Q3 guidance calls for flat FX-neutral subscription growth.

$VTEXMedAI 8/10

VTEX Q2 Earnings Call Highlights

VTEX (NYSE:VTEX) reported Q2 margin and cash flow improvement and guided for Q3 and full-year low-single-digit FX-neutral subscription revenue growth and low-20% non-GAAP operating and free cash flow margins. Q2 non-GAAP subscription gross margin rose to 81.8%. Free cash flow rose 79% to $12.7M. VTEX repurchased 6.2M shares at $3.76.

$VTEXMed

VTEX (VTEX): Financial results for Q2 2026

VTEX (VTEX) furnished an SEC Form 6-K — earnings release. VTEX Reports Second Quarter 2026 Financial Results Subscription revenue grew 11.4% (+1.3% FXN), with GMV up 17.8% (+7.0% FXN) Non-GAAP income from operations increased 62.4% to US$13.8 million, reaching a 21.4% margin Free cash flow increased 79.1% to US$12.7 million, reaching a